Luke M Beshar - Net Worth and Insider Trading
Luke M Beshar Net Worth
The estimated net worth of Luke M Beshar is at least $388,080 dollars as of 2024-09-20. Luke M Beshar is the Director of Protara Therapeutics Inc and owns about 198,000 shares of Protara Therapeutics Inc (TARA) stock worth over $388,080. Luke M Beshar is also the Director of Regenxbio Inc and owns about 0 shares of Regenxbio Inc (RGNX) stock worth over $0. Details can be seen in Luke M Beshar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luke M Beshar has not made any transactions after 2022-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Luke M Beshar
Luke M Beshar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Luke M Beshar owns 3 companies in total, including Protara Therapeutics Inc (TARA) , Regenxbio Inc (RGNX) , and Omega Therapeutics Inc (OMGA) .
Click here to see the complete history of Luke M Beshar’s form 4 insider trades.
Insider Ownership Summary of Luke M Beshar
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TARA | Protara Therapeutics Inc | 2022-06-30 | director |
RGNX | Regenxbio Inc | 2018-11-29 | director |
OMGA | Omega Therapeutics Inc | 2021-07-29 | director |
Luke M Beshar Latest Holdings Summary
Luke M Beshar currently owns a total of 2 stocks. Among these stocks, Luke M Beshar owns 198,000 shares of Protara Therapeutics Inc (TARA) as of June 30, 2022, with a value of $388,080 and a weighting of 100%. Luke M Beshar also owns 0 shares of Regenxbio Inc (RGNX) as of November 29, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Luke M Beshar
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TARA | Protara Therapeutics Inc | 2022-06-30 | 198,000 | 1.96 | 388,080 |
RGNX | Regenxbio Inc | 2018-11-29 | 0 | 12.50 | 0 |
Holding Weightings of Luke M Beshar
Luke M Beshar Form 4 Trading Tracker
According to the SEC Form 4 filings, Luke M Beshar has made a total of 3 transactions in Protara Therapeutics Inc (TARA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Protara Therapeutics Inc is the acquisition of 10,000 shares on June 30, 2022, which cost Luke M Beshar around $31,000.
According to the SEC Form 4 filings, Luke M Beshar has made a total of 0 transactions in Regenxbio Inc (RGNX) over the past 5 years. The most-recent trade in Regenxbio Inc is the sale of 12,784 shares on November 29, 2018, which brought Luke M Beshar around $830,960.
Insider Trading History of Luke M Beshar
- 1
Luke M Beshar Trading Performance
GuruFocus tracks the stock performance after each of Luke M Beshar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luke M Beshar is -17.58%. GuruFocus also compares Luke M Beshar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luke M Beshar within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Luke M Beshar's insider trading performs compared to the benchmark.
Performance of Luke M Beshar
Luke M Beshar Ownership Network
Luke M Beshar Owned Company Details
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Luke M Beshar is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Luke M Beshar made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 392,421 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 392,421 shares. During the past 18 months, 703,460 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 703,460 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
Luke M Beshar Mailing Address
Above is the net worth, insider trading, and ownership report for Luke M Beshar. You might contact Luke M Beshar via mailing address: 550 Hills Drive, 3rd Floor, Bedminster Nj 07921.